RecruitingNCT05407480
Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
Therapeutic Recommendations for Children Registered in the RFAOP Register and With a Hodgkin Lymphoma
Sponsor
French Africa Pediatric Oncology Group
Enrollment
250 participants
Start Date
Nov 15, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data. Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.
Eligibility
Min Age: 0 MonthsMax Age: 18 Years
Inclusion Criteria3
- under 18 years of age at diagnosis
- suffering from "classical" Hodgkin's disease according to the WHO classification.
- with no history of hematological malignancies or constitutional or acquired immune deficiencies
Exclusion Criteria2
- Over 18 years of age at diagnosis
- A history of hematological malignancies or a history of constitutional or a history of acquired immune deficiencies
Interventions
OTHERObservational
Descriptive data will be collected to evaluation compliance with the protocol and to evaluate outcome
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05407480
Related Trials
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
NCT070985981 location
Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
NCT070510831 location
Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer
NCT067759771 location